1. Leveraging single-cell transcriptomic data to uncover immune suppressive cancer cell subsets in triple-negative canine breast cancers
   Myung-Chul Kim et al, 2024, Frontiers in Veterinary Science CrossRef
2. Protein Expression of PI3K/AKT/mTOR Pathway Targets Validated by Gene Expression and its Correlation with Prognosis in Canine Mammary Cancer
   Isabela F. S. Perossi et al, 2022, Journal of Mammary Gland Biology and Neoplasia CrossRef
3. Engineering and Studying Syngeneic Animal Tumors and Large Animal Endogenous Tumor Models
   K. Suganya et al, 2023, Handbook of Animal Models and its Uses in Cancer Research CrossRef
4. Current invasive and non-invasive biomarkers in canine mammary tumors
   Aslihan BAYKAL et al, 2021, Journal of Istanbul Veterinary Sciences CrossRef
5. Canine Mammary Tumors as a Potential Model for Human Breast Cancer in Comparative Oncology
   Amirhossein Razavirad et al, 2024, Veterinary Medicine International CrossRef
6. Are c-erb B2 and UGCG Reliable Immunohistochemical Markers Of Canine Mammary Carcinomas?
   Emin KARAKURT et al, 2021, Atatürk Üniversitesi Veteriner Bilimleri Dergisi CrossRef
7. Cutaneous metastasis of mammary gland tumor in a dog: a case report
   Hyejoon Choi et al, 2022, Korean Journal of Veterinary Research CrossRef
8. Hyperresistinemia in Obese Female Dogs With Mammary Carcinoma in Benign-Mixed Tumors and Its Correlation With Tumor Aggressiveness and Survival
   Bianca Oliveira Nicchio et al, 2020, Frontiers in Veterinary Science CrossRef
9. From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive Review
   Guillermo Valdivia et al, 2021, Frontiers in Veterinary Science CrossRef
10. Treatment of Triple Negative Cell Lines with Olaparib to Block DNA Repair
    Marina Gobbe Moschetta-Pinheiro et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
11. Engineering and studying syngeneic animal tumors and Large animal endogenous tumor models
    K. Suganya et al, 2022, Handbook of Animal Models and its Uses in Cancer Research CrossRef